Christine Tjaden

Toward the blood-borne miRNome of human diseases

Andreas Keller, Petra Leidinger, Andrea S. Bauer et al. · Nature Methods · 2011 · 360 citations

Disease Mechanism, Medicine, Pathogenesis +5

Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial

Paula Ghaneh, Daniel H. Palmer, Silvia Cicconi et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 294 citations · Full text

Surgical Oncology, Immediate Surgery, Pancreatic Cancer +7

Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma

Robert Jones, Eftychia‐Eirini Psarelli, Richard Jackson et al. · JAMA Surgery · 2019 · 256 citations · Full text

Radical surgery of oligometastatic pancreatic cancer

Thilo Hackert, Willem Niesen, Ulf Hinz et al. · European Journal of Surgical Oncology · 2016 · 233 citations

Surgical Oncology, Pancreatic Cancer, Medicine +4

ESPAC-5F: Four-arm, prospective, multicenter, international randomized phase II trial of immediate surgery compared with neoadjuvant gemcitabine plus capecitabine (GEMCAP) or FOLFIRINOX or chemoradiotherapy (CRT) in patients with borderline resectable pancreatic cancer.

Paula Ghaneh, Daniel H. Palmer, Silvia Cicconi et al. · Journal of Clinical Oncology · 2020 · 164 citations

Surgical Oncology, Neoadjuvant Therapy, Cancer Management +17